EHT 0202 Uses, Dosage, Side Effects and more
EHT 0202 is developed to treat neurodegenerative disorders by ExonHit Therapeutics.
| Trade Name | EHT 0202 |
| Generic | EHT 0202 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in alzheimer's disease and neurologic disorders.
How EHT 0202 works
EHT 0202 was discovered to play a role in protecting neurons in pharmacological models of neuronal cell death. ExonHit identified RNA isoforms produced by alterations of splicing specifically taking place in neurodegenerative disease models. These isoforms were identified using DATAS(TM), ExonHit's proprietary gene profiling technology. DATAS(TM), stands for Differential Analysis of Transcripts with Alternative Splicing.
